Altamira Therapeutics Ltd. Soared
Mon, Mar 25, 2024 at 07:25 PM
Altamira Therapeutics Ltd. (CYTO:NASDAQ) jumped higher at $2.35, a gain of 36.6%. On Mon, Mar 25, 2024, CYTO:NASDAQ touched a New 2-Week High of $2.35. The stock appeared on our News Catalysts scanner on Mon, Mar 25, 2024 at 11:32 AM in the 'PATNERSHIP' category. From Mon, Mar 11, 2024, the stock recorded 40.00% Up Days and 18.18% Green Days
The stock spiked on Mon, Mar 25, 2024 at $3.49 with a volume of 62M+.
About Altamira Therapeutics Ltd. (CYTO:NASDAQ)
Altamira Therapeutics Ltd is dedicated to developing therapeutics that address unmet medical needs. It is active in RNA therapeutics, allergy and viral infections, and inner ear disorders.
Top 10 Gainers:
- Landos Biopharma Inc. (LABP:NASDAQ), 167.5%
- F45 Training Holdings Inc. (FXLV:NYSE), 66.67%
- MoneyHero Limited (MNY:NASDAQ), 63.5%
- Linkage Global Inc (LGCB:NASDAQ), 46.4%
- Altamira Therapeutics Ltd. (CYTO:NASDAQ), 36.63%
- Puyi Inc. (PUYI:NASDAQ), 33.93%
- noco-noco Inc. (NCNC:NASDAQ), 30.46%
- Reddit Inc. Class A (RDDT:NYSE), 30%
- Earlyworks Co. Ltd. (ELWS:NASDAQ), 29.8%
- Next.e.GO N.V. (EGOX:NASDAQ), 29.52%